These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 3587618

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Adrenoleukodystrophy in children. Apropos of 20 cases].
    Aubourg P, Chaussain JL, Dulac O, Arthuis M.
    Arch Fr Pediatr; 1982 Nov; 39(9):663-9. PubMed ID: 6299222
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
    Rizzo WB, Watkins PA, Phillips MW, Cranin D, Campbell B, Avigan J.
    Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Late onset adrenomyeloneuropathy.
    Jeffcoate WJ, McGivern D, Cotton RE, Hopkinson GR.
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1238-9. PubMed ID: 3668578
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Adrenoleukodystrophy in a mother and son.
    Simpson RH, Rodda J, Reinecke CJ.
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1165-72. PubMed ID: 2822858
    [Abstract] [Full Text] [Related]

  • 31. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
    O'Neill BP, Moser HW, Saxena KM, Marmion LC.
    Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
    [Abstract] [Full Text] [Related]

  • 32. Problems in diagnosing diffuse cerebral sclerosis.
    Wender M, Goncerzewicz A, Adamczewska-Goncerzewicz Z.
    Neuropatol Pol; 1986 Jun; 24(4):455-70. PubMed ID: 3587651
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: II. Lipid biochemical studies.
    Taketomi T, Hara A, Kitazawa N, Takada K, Nakamura H.
    Jpn J Exp Med; 1987 Feb; 57(1):59-70. PubMed ID: 3476777
    [Abstract] [Full Text] [Related]

  • 36. Morphology and distribution of cytoplasmic inclusions in adrenoleukodystrophy.
    Ghatak NR, Nochlin D, Peris M, Myer EC.
    J Neurol Sci; 1981 Jun; 50(3):391-8. PubMed ID: 6267207
    [Abstract] [Full Text] [Related]

  • 37. [An atypical case of adrenoleukodystrophy (ALD) with frontal lobe syndrome and slow progression].
    Arai Y, Matsuzaka T, Toyoda M, Sakuragawa N, Arima M.
    No To Hattatsu; 1988 Jan; 20(1):33-7. PubMed ID: 3279980
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adrenoleukodystrophy with olivopontocerebellar atrophy-like lesions.
    Tateishi J, Sato Y, Suetsugu M, Takashiba T.
    Clin Neuropathol; 1986 Jan; 5(1):34-9. PubMed ID: 3948452
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.